A controversial blood test aimed at detecting multiple cancers was backed by a U.S. Food and Drug Administration panel.

A Bay Area biotech company appears to be one major step closer to receiving final federal approval for its groundbreaking ...

Or had her cancer returned? “Because I have the BRCA2 gene, I have a higher chance of the cancer coming back,” she says. “The ...

Recent research suggests that monitoring blood test trends over time, rather than focusing on a single test, may help ...

The panelists expressed reservations about the evidence supporting Grail’s Galleri test, which is designed to detect cancers ...

The impact of fasting on blood test results is analyte-specific, with most routine tests showing minimal differences, ...

A team of researchers in China has built a machine learning system that can identify gastrointestinal stromal tumors, one of ...

The test can spot the brain plaques that define Alzheimer’s long before a diagnosis would normally be on the table.

Only Abbott offers a complete screening solution combining end-to-end support with both stool- and blood-based colorectal ...